AIDS-associated Burkitt or Burkitt-like lymphoma: Short intensive polychemotherapy is feasible and effective

References

• Spina M, Tirelli U, Zagonel V, Gloghini A, Volpe R, Barbare R, et al. Burkitt's lymphoma in adults with and without human immunodeficiency virus infection: a single-institution clinicopathologic study of 75 patients. Cancer 1998; 82: 766–774
   PubMed Web of Science ®Google Scholar
• Straus D J. Treatment of Burkitt's lymphoma in HIV-positive patients. Biomed Pharmacother 1996; 50: 447–450
   PubMed Web of Science ®Google Scholar
• International Collaboration on HIV and Cancer. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 2000; 92: 1823–1830
   PubMed Web of Science ®Google Scholar
• Kirk O, Pedersen C, Cozzi-Lepri A, Antunes F, Miller V, Gatell J M, et al. Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy. Blood 2001; 98: 3406–3412
   PubMed Web of Science ®Google Scholar
• Ziegler J L, Drew W L, Miner R C, Mintz L, Rosenbaum E, Gershow J, et al. Outbreak of Burkitt's-like lymphoma in homosexual men. Lancet 1982; 2: 631–633
   PubMed Web of Science ®Google Scholar
• Moses A, Nelson J, Bagby G C, Jr. The influence of human immunodeficiency virus-1 on hematopoiesis. Blood 1998; 91: 1479–1495
   PubMed Web of Science ®Google Scholar
• Carbone A, Gloghini A, Gaidano G, Cilia A M, Bassi P, Polito P, et al. AIDS-related Burkitt's lymphoma. Morphologic and immunophenotypic study of biopsy specimens. Am J Clin Pathol 1995; 103: 561–567
   PubMed Web of Science ®Google Scholar
• Roithmann S, Toledano M, Tourani J M, Raphael M, Gentilini M, Gastaut J A, et al. HIV-associated non-Hodgkin's lymphomas: clinical characteristics and outcome. The experience of the French Registry of HIV-associated tumors. Ann Oncol 1991; 2: 289–295
   PubMed Web of Science ®Google Scholar
• Davi F, Delecluse H J, Guiet P, Gabarrre J, Fayon A, Gentilhomme O, et al. Burkitt-like lymphomas in AIDS patients: characterization within a series of 103 human immunodeficiency virus-associated non-Hodgkin's lymphomas. Burkitt's Lymphoma Study Group. J Clin Oncol 1998; 16: 3788–3795
   PubMed Web of Science ®Google Scholar
• Hoelzer D, Ludwig W D, Thiel E, Gassmann W, Loeffler H, Fonatsch C, et al. Improved outcome in adult B-cell acute lymphoblastic leukemia. Blood 1996; 87: 495–508
   PubMed Web of Science ®Google Scholar
• Magrath I, Adde M, Shad A, Venzon D, Seibel N, Gootenberg J, et al. Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol 1996; 14: 925
   PubMed Web of Science ®Google Scholar
• Antinori A, Cingolani A, Alba L, Ammassari A, Serraino D, Ciancio B C, et al. Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy. AIDS 2001; 15: 1483–1491
   PubMed Web of Science ®Google Scholar
• Ratner L, Lee J, Tang S, Redden D, Hamzeh F, Herndier B, et al. Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy. J Clin Oncol 2001; 19: 2171–2178
   PubMed Web of Science ®Google Scholar
• Powles T, Imami N, Nelson M, Gazzard B G, Bower M. Effects of combination chemotherapy and highly active antiretroviral therapy on immune parameters in HIV-1 associated lymphoma. AIDS 2002; 16: 531–536
   PubMed Web of Science ®Google Scholar
• Gerard L, Galicier L, Maillard A, Boulanger E, Quint L, Matheron S, et al. Systemic non-Hodgkin lymphoma in HIV-infected patients with effective suppression of HIV replication: persistent occurrence but improved survival. J Acquir Immune Defic Syndr 2002; 30: 478–484
   PubMed Web of Science ®Google Scholar
• Hoffmann C, Wolf E, Faetkenheuer G, Buhk T, Stoehr A, Plettenberg A, et al. Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphoma. AIDS 2003; 10: 1521–1529
   Web of Science ®Google Scholar
• Carbone P P, Kaplan H S, Musshoff K, Smithers D W, Tubiana M. Report of the committee on Hodgkin's disease staging classification. Cancer Res 1971; 31: 1860–1861
   PubMed Web of Science ®Google Scholar
• Cheson B D, Horning S J, Coiffier B, Shipp M A, Fisher R I, Connors J M, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. J Clin Oncol 1999; 17: 1244–1252
   PubMed Web of Science ®Google Scholar
• Harris N L, Jaffe E S, Diebold J, Flandrin G, Mueller-Hermelink H K, Vardiman J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17: 3835–3849
   PubMed Web of Science ®Google Scholar
• Goekbuget N, Hoelzer D, Arnold R, Bohme A, Bartram C R, Freund M, et al. Treatment of adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL). Hematol Oncol Clin North Am 2000; 14: 1307–1325
   PubMed Web of Science ®Google Scholar
• Hoelzer D, Arnold R, Diedrich H, Faak T, Ganser A, Horst H A, et al. Successful treatment of Burkitt's NHL and other high-grade NHL according to a protocol for mature B-ALL [Abstract 595]. Presented at 44^th Annual Meeting of the American Society of Hematology. Philadelphia 2002
   Google Scholar
• Hoelzer D, Baur K H, Giagounidis A, Ludwig W L., Glasmacher A, Duehrsen U, et al. Short intensive chemotherapy with rituximab seems successful in Burkitt NHL, mature B-ALL and other high-grade B-NHL [Abstract 236]. Presented at 45^th Annual Meeting of the American Society of Hematology. San Diego 2003
   Google Scholar
• Lim S T, Karim R, Nathwani B N, Tulpule A, Espina B, Levine A M. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy. J Clin Oncol 2005; 23: 4430–4438
   PubMed Web of Science ®Google Scholar
• Oriol A, Ribera J M, Esteve J, Sanz M A, Brunet S, Garcia-Boyero R, et al. Lack of influence of human immunodeficiency virus infection status in the response to therapy and survival of adult patients with mature B-cell lymphoma or leukemia. Results of the PETHEMA-LAL3/97 study. Haematologica 2003; 88: 445–453
   PubMed Web of Science ®Google Scholar
• Conti S, Masocco M, Pezzotti P, Toccaceli V, Vichi M, Boros S, et al. Differential impact of combined antiretroviral therapy on the survival of italian patients with specific AIDS-defining illnesses. J Acquir Immune Defic Syndr 2000; 25: 451–458
   PubMed Web of Science ®Google Scholar
• Astrow A B, Tarabay G, Salerno V E, Cook W A, Lin R, Lascher S, et al. Long-term survival in patients with human immunodeficiency virus-associated small non-cleaved cell lymphoma: the role for short course intensive chemotherapy. Hematol Oncol 2003; 21: 131–140
   PubMed Web of Science ®Google Scholar
• Cortes J, Thomas D, Rios A, Koller C, O'Brien S, Jeha S, et al. Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma/leukemia. Cancer 2002; 94: 1492–1499
   PubMed Web of Science ®Google Scholar
• Fieschi C, Boulanger E, Galicier L, Daniel M T, Clauvel J P, Oksenhendler E. Intensive chemotherapy (LMB 86) regimen for HIV-associated stage IV Burkitt's lymphoma/leukaemia [Abstract 592]. Presented at 8^th Conference on Retroviruses and Opportunistic Infections. Chicago 2001
   Google Scholar
• Lichtman S M, Calderon N. Alternating codox-m and ivac in HIV positive patients with burkitt's lymphoma [Abstract 2471]. Presented at ASCO Annual Meeting. Chicago 2003
   Google Scholar
• Wang E S, Straus D J, Teruya-Feldstein J, Qin J, Portlock C, Moskowitz C, et al. Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma. Cancer 2003; 98: 1196–1205
   PubMed Web of Science ®Google Scholar